Pipeline
Dystrogen Therapeutics is focused on the development of Cell Therapy Platform.
| Program | Indications | Phase |
|---|---|---|
DT-DEC01 | DMD |
|
DT-200 | Neuro-Degenerative |
|
DT-201 | Sarcopenia |
|
DT-202 | Age related muscle loss |
|
Candidates developed under Chimeric Cell platform: